Illumina
ILMN today introduced the HiSeq® 2500, a next-generation sequencing system that will enable researchers and clinicians to sequence an entire genome in approximately 24 hours, “Genome in a Day”. The HiSeq 2500 leverages the continued technology advancements from both the HiSeq 2000 and MiSeq™ platforms.
“The ability to sequence an entire genome in a day with the same high quality data as the HiSeq 2000 will enable new opportunities for researchers to develop medically relevant whole-genome applications,” said Jay Flatley, President and Chief Executive Officer at Illumina. “With the HiSeq 2500, Illumina is taking another significant step forward in enabling our vision of revolutionizing human healthcare.”
The HiSeq 2500 offers:
Unprecedented Speed and Flexibility – two modes allow researchers to generate 120 gigabases (Gb) of data in 27 hours, or 600 Gb in a standard HiSeq run.
High Quality Data- system uses the proven SBS chemistry that has made both the HiSeq 2000 and the MiSeq systems the most accurate next-generation sequencers.
Expanding Applications – enables researchers to sequence a human genome or 20 exomes in a day, or 30 RNA sequencing samples in as little as five hours.
Industry Leading Simplicity and Ease-of-Use – integrated cluster generation process enables a simplified workflow similar the MiSeq platform.
Upgradable from HiSeq 2000 – through a simple, field-based upgrade priced at $50,000
Loading...
Loading...
ILMNIllumina Inc
$88.500.59%
Edge Rankings
Momentum
15.25
Growth
21.32
Quality
5.43
Value
23.74
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in